SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
- PMID: 32387541
- PMCID: PMC7204754
- DOI: 10.1053/j.gastro.2020.05.009
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
Keywords: ACE, angiotensin-converting enzyme; COVID-19, Coronavirus Disease 2019; IBD, inflammatory bowel disease; OR, odds ratio; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2.
Comment in
-
What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?Gastroenterology. 2021 Apr;160(5):1901-1902. doi: 10.1053/j.gastro.2020.05.099. Epub 2020 Jul 17. Gastroenterology. 2021. PMID: 32687925 Free PMC article. No abstract available.
-
Reply.Gastroenterology. 2021 Apr;160(5):1902-1903. doi: 10.1053/j.gastro.2021.01.014. Epub 2021 Jan 13. Gastroenterology. 2021. PMID: 33453234 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous